By: Sara Riascos  Apr. 16, 2022

Sepsis is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payors such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Cefuroxime is an antibiotic used to treat bacterial infections of the ear, nose, throat, lungs, skin, bones, joints, bladder, or kidneys. Studies have shown that Cefuroxime significantly reduced the frequency of sepsis after TRUSBP.

By: Sara Riascos  Mar. 14, 2022

Myocardial Infarction is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Brilinta(Ticagrelor) is an oral antiplatelet prescribed by doctors to reduce the risk of having, or dying from a heart attack or stroke. Studies have shown that the use of Brilinta(Ticagrelor) reduces the risk of death from vascular causes, myocardial infarctions, and strokes. Brilinta is also approved in more than 110 countries to prevent atherothrombotic events after a myocardial infarction.

By: Avinash Kumar  Feb. 10, 2020

Dexur utilized Medicare claims data from 2014-Q2 to 2019-Q2 to analyze the market share of Yale New Haven Hospital of New Haven County on different metrics like Specialties, Conditions, DRG groups, Outpatient ER Visits, Hospitalizations via ER.

By: Emily Carpintero  Nov. 15, 2017

Pulmonary embolism (PE) is a condition where one or more arteries in the lungs is blocked with a blood clot. It is often a secondary cause of deep vein thrombosis (DVT) and in serious cases PE can lead to mortality. Researchers of Yale-New Haven Hospital have conducted and participated in numerous studies pertaining to pulmonary embolism.